Search

Suzanne Marie Noakes

Examiner (ID: 8754, Phone: (571)272-2924 , Office: P/1656 )

Most Active Art Unit
1656
Art Unit(s)
1656, 1653
Total Applications
1752
Issued Applications
1110
Pending Applications
203
Abandoned Applications
459

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 20059612 [patent_doc_number] => 20250197834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-19 [patent_title] => PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 19/071092 [patent_app_country] => US [patent_app_date] => 2025-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 140575 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19071092 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/071092
PH20 POLYPEPTIDE VARIANTS, FORMULATIONS AND USES THEREOF Mar 4, 2025 Pending
Array ( [id] => 20059615 [patent_doc_number] => 20250197837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-19 [patent_title] => SERINE PROTEASE FOR SELECTIVELY DEGRADING MUCINS AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 19/069321 [patent_app_country] => US [patent_app_date] => 2025-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3347 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19069321 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/069321
SERINE PROTEASE FOR SELECTIVELY DEGRADING MUCINS AND USE THEREOF Mar 3, 2025 Pending
Array ( [id] => 20121816 [patent_doc_number] => 20250236847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-07-24 [patent_title] => COMPOSITIONS AND METHODS FOR EPIGENETIC REGULATION OF HBV GENE EXPRESSION [patent_app_type] => utility [patent_app_number] => 19/060404 [patent_app_country] => US [patent_app_date] => 2025-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40154 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 190 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19060404 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/060404
COMPOSITIONS AND METHODS FOR EPIGENETIC REGULATION OF HBV GENE EXPRESSION Feb 20, 2025 Pending
Array ( [id] => 19877138 [patent_doc_number] => 20250109395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-03 [patent_title] => S. PYOGENES CAS9 MUTANT GENES AND POLYPEPTIDES ENCODED BY SAME [patent_app_type] => utility [patent_app_number] => 18/970552 [patent_app_country] => US [patent_app_date] => 2024-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12498 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18970552 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/970552
S. pyogenes CAS9 mutant genes and polypeptides encoded by same Dec 4, 2024 Issued
Array ( [id] => 20393473 [patent_doc_number] => 20250368948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-12-04 [patent_title] => PRODUCT, SYSTEM AND METHOD OF CELL CULTIVATION [patent_app_type] => utility [patent_app_number] => 18/927171 [patent_app_country] => US [patent_app_date] => 2024-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 125322 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18927171 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/927171
PRODUCT, SYSTEM AND METHOD OF CELL CULTIVATION Oct 24, 2024 Pending
Array ( [id] => 19855764 [patent_doc_number] => 12258588 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-03-25 [patent_title] => Fusion polypeptides for production of 7-dehydrocholesterol and methods of use thereof [patent_app_type] => utility [patent_app_number] => 18/919946 [patent_app_country] => US [patent_app_date] => 2024-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 9 [patent_no_of_words] => 13318 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18919946 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/919946
Fusion polypeptides for production of 7-dehydrocholesterol and methods of use thereof Oct 17, 2024 Issued
Array ( [id] => 19877133 [patent_doc_number] => 20250109390 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-03 [patent_title] => COMPOSITIONS FOR PREVENTING OR TREATING CORONAVIRUS INFECTIONS [patent_app_type] => utility [patent_app_number] => 18/914016 [patent_app_country] => US [patent_app_date] => 2024-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 68448 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18914016 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/914016
Compositions for preventing or treating coronavirus infections Oct 10, 2024 Issued
Array ( [id] => 19809737 [patent_doc_number] => 12241109 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-03-04 [patent_title] => Host cells comprising a recombinant casein protein and a recombinant kinase protein [patent_app_type] => utility [patent_app_number] => 18/886925 [patent_app_country] => US [patent_app_date] => 2024-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 43 [patent_no_of_words] => 90167 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18886925 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/886925
Host cells comprising a recombinant casein protein and a recombinant kinase protein Sep 15, 2024 Issued
Array ( [id] => 19693205 [patent_doc_number] => 20250011750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-09 [patent_title] => VARIANT OF ASPARTATE 1-DECARBOXYLASE DERIVED FROM T. CASTANEUM AND MICROORGANISMS INCLUDING SAME [patent_app_type] => utility [patent_app_number] => 18/885239 [patent_app_country] => US [patent_app_date] => 2024-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12526 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18885239 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/885239
VARIANT OF ASPARTATE 1-DECARBOXYLASE DERIVED FROM T. CASTANEUM AND MICROORGANISMS INCLUDING SAME Sep 12, 2024 Pending
Array ( [id] => 20793870 [patent_doc_number] => 20260174764 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-06-25 [patent_title] => COMPOSITION AND METHOD FOR REMOVING PLAQUE FROM AN ARTERY [patent_app_type] => utility [patent_app_number] => 19/110409 [patent_app_country] => US [patent_app_date] => 2024-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19110409 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/110409
COMPOSITION AND METHOD FOR REMOVING PLAQUE FROM AN ARTERY Sep 11, 2024 Pending
Array ( [id] => 19682411 [patent_doc_number] => 20250000956 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-02 [patent_title] => RECOMBINANT CELL WALL HYDROLASES [patent_app_type] => utility [patent_app_number] => 18/882318 [patent_app_country] => US [patent_app_date] => 2024-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22067 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18882318 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/882318
Recombinant cell wall hydrolases Sep 10, 2024 Issued
Array ( [id] => 20059650 [patent_doc_number] => 20250197872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-19 [patent_title] => ALLULOSE EPIMERASE EXPRESSION CASSETTE AND MANUFACTURING METHOD OF ALLULOSE USING THE SAME [patent_app_type] => utility [patent_app_number] => 18/808665 [patent_app_country] => US [patent_app_date] => 2024-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 802 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18808665 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/808665
ALLULOSE EPIMERASE EXPRESSION CASSETTE AND MANUFACTURING METHOD OF ALLULOSE USING THE SAME Aug 18, 2024 Pending
Array ( [id] => 19991125 [patent_doc_number] => 20250129347 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-24 [patent_title] => ENGINEERED HUMAN EXTRACELLULAR DNASE ENZYMES [patent_app_type] => utility [patent_app_number] => 18/798042 [patent_app_country] => US [patent_app_date] => 2024-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13311 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18798042 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/798042
ENGINEERED HUMAN EXTRACELLULAR DNASE ENZYMES Aug 7, 2024 Pending
Array ( [id] => 19800825 [patent_doc_number] => 20250066750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-27 [patent_title] => Streptococcus Canis Cas9 as a Genome Engineering Platform with Novel PAM Specificity [patent_app_type] => utility [patent_app_number] => 18/795872 [patent_app_country] => US [patent_app_date] => 2024-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10238 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18795872 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/795872
Streptococcus Canis Cas9 as a Genome Engineering Platform with Novel PAM Specificity Aug 5, 2024 Pending
Array ( [id] => 20033527 [patent_doc_number] => 20250171749 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-05-29 [patent_title] => GENETICALLY MODIFIED ORGANISMS FOR PRODUCING PSYCHOTROPIC ALKALOIDS [patent_app_type] => utility [patent_app_number] => 18/790714 [patent_app_country] => US [patent_app_date] => 2024-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 65725 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18790714 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/790714
GENETICALLY MODIFIED ORGANISMS FOR PRODUCING PSYCHOTROPIC ALKALOIDS Jul 30, 2024 Pending
Array ( [id] => 20048343 [patent_doc_number] => 20250186565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-12 [patent_title] => CERAMIDE LEVELS IN THE TREATMENT AND PREVENTION OF INFECTIONS [patent_app_type] => utility [patent_app_number] => 18/777129 [patent_app_country] => US [patent_app_date] => 2024-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4285 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18777129 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/777129
CERAMIDE LEVELS IN THE TREATMENT AND PREVENTION OF INFECTIONS Jul 17, 2024 Pending
Array ( [id] => 19631460 [patent_doc_number] => 20240409909 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-12 [patent_title] => ALPHA-AMYLASE VARIANTS [patent_app_type] => utility [patent_app_number] => 18/774233 [patent_app_country] => US [patent_app_date] => 2024-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24460 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18774233 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/774233
ALPHA-AMYLASE VARIANTS Jul 15, 2024 Pending
Array ( [id] => 20059649 [patent_doc_number] => 20250197871 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-19 [patent_title] => PROMOTER FOR CONSTITUTIVE EXPRESSION, TARGET PROTEIN EXPRESSION SYSTEM INCLUDING SAME, AND MANUFACTURING METHOD OF ALLULOSE USING THE SAME [patent_app_type] => utility [patent_app_number] => 18/772544 [patent_app_country] => US [patent_app_date] => 2024-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2022 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18772544 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/772544
PROMOTER FOR CONSTITUTIVE EXPRESSION, TARGET PROTEIN EXPRESSION SYSTEM INCLUDING SAME, AND MANUFACTURING METHOD OF ALLULOSE USING THE SAME Jul 14, 2024 Pending
Array ( [id] => 19746032 [patent_doc_number] => 20250034597 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-30 [patent_title] => RNA-Guided Targeting of Genetic and Epigenomic Regulatory Proteins to Specific Genomic Loci [patent_app_type] => utility [patent_app_number] => 18/764634 [patent_app_country] => US [patent_app_date] => 2024-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11128 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18764634 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/764634
RNA-Guided Targeting of Genetic and Epigenomic Regulatory Proteins to Specific Genomic Loci Jul 4, 2024 Pending
Array ( [id] => 19685445 [patent_doc_number] => 20250003990 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-02 [patent_title] => ASSAYS, CARTRIDGES, AND KITS FOR DETECTION OF BIOMARKERS, INCLUDING BRAIN INJURY BIOMARKERS [patent_app_type] => utility [patent_app_number] => 18/761632 [patent_app_country] => US [patent_app_date] => 2024-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 74912 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18761632 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/761632
ASSAYS, CARTRIDGES, AND KITS FOR DETECTION OF BIOMARKERS, INCLUDING BRAIN INJURY BIOMARKERS Jul 1, 2024 Pending
Menu